T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Energy Vault
NRGV
$691M
| $99K | ﹤0.01% |
54,933
+7,930
| +17% | +$13.9K |
|
2777
Safe Bulkers
SB
$778M
| $99K | ﹤0.01% |
19,945
+4,129
| +26% | +$18.2K |
|
2778
Revolution Medicines Inc Warrant
RVMDW
$124M
| $98K | ﹤0.01% |
607,436
-1,038
| -0.2% | -$210 |
|
|
SUP
2779
DELISTED
Superior Industries International
SUP
| $98K | ﹤0.01% |
33,700
| – | – |
|
2780
Viemed Healthcare
VMD
$355M
| $97K | ﹤0.01% |
+10,210
| New | +$87.5K |
|
|
AGS
2781
DELISTED
PlayAGS
AGS
| $96K | ﹤0.01% |
+10,627
| New | +$92.8K |
|
2782
Custom Truck One Source
CTOS
$2.42B
| $96K | ﹤0.01% |
16,395
+2,882
| +21% | +$17.9K |
|
|
ESPR
2783
DELISTED
Esperion Therapeutics
ESPR
| $95K | ﹤0.01% |
35,400
| – | – |
|
2784
Lindblad Expeditions
LIND
$2.25B
| $95K | ﹤0.01% |
+10,117
| New | +$93.2K |
|
2785
Arbutus Biopharma
ABUS
$904M
| $94K | ﹤0.01% |
36,388
+6,649
| +22% | +$17.2K |
|
2786
Clarus
CLAR
$144M
| $94K | ﹤0.01% |
13,742
+237
| +2% | +$1.46K |
|
|
VOXX
2787
DELISTED
VOXX International Corporation Class A
VOXX
| $94K | ﹤0.01% |
11,427
| – | – |
|
2788
Sagimet Biosciences
SGMT
$569M
| $91K | ﹤0.01% |
+16,705
| New | +$120K |
|
2789
Neuronetics
STIM
$228M
| $91K | ﹤0.01% |
19,100
| – | – |
|
2790
Kartoon Studios
TOON
$38.4M
| $91K | ﹤0.01% |
66,240
| – | – |
|
|
VTNR
2791
DELISTED
Vertex Energy, Inc
VTNR
| $91K | ﹤0.01% |
64,976
+28,700
| +79% | +$45.8K |
|
2792
Angi Inc
ANGI
$187M
| $90K | ﹤0.01% |
3,400
| – | – |
|
|
LUNA
2793
DELISTED
Luna Innovations Incorporated
LUNA
| $90K | ﹤0.01% |
27,963
+2,503
| +10% | +$15.9K |
|
2794
Pulse Biosciences
PLSE
$3.21B
| $88K | ﹤0.01% |
+10,009
| New | +$92K |
|
2795
Mammoth Energy Services
TUSK
$156M
| $87K | ﹤0.01% |
23,735
+409
| +2% | +$1.54K |
|
2796
Solid Power
SLDP
$536M
| $85K | ﹤0.01% |
41,686
+5,050
| +14% | +$7.69K |
|
|
WW
2797
DELISTED
WW International
WW
| $85K | ﹤0.01% |
45,474
+3,106
| +7% | +$12.4K |
|
2798
uniQure
QURE
$3.24B
| $84K | ﹤0.01% |
16,100
| – | – |
|
2799
Heron Therapeutics
HRTX
$62.7M
| $83K | ﹤0.01% |
29,922
+3,991
| +15% | +$10K |
|
2800
SelectQuote
SLQT
$129M
| $83K | ﹤0.01% |
41,414
+6,555
| +19% | +$9.8K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.